BioSpace News Archive

Drug Development

Atara Announces Two Presentations at 59th American Society of Hematology Annual Meeting, Including Positive Interim Results From a Multicenter Expanded Access Study of ATA129 for Patients with Epstein-Barr Virus-Associated Cancers

The Company’s collaborating investigators at Memorial Sloan Kettering Cancer Center will present, on behalf of eight major transplant centers in the U.S.

November 1, 2017

·

12 min read

Business

Aprecia Pharma Names University of Kentucky Provost as the Company’s Next CEO

Aprecia Pharma announced today that Dr. Timothy Tracy will serve as the company’s next CEO, beginning in January 2018.

November 1, 2017

·

3 min read

BioCapital

DowDuPont Announces Completion of DuPont’s Transactions With FMC

DowDuPont today announced that DuPont has completed its acquisition of FMC Corporation’s Health & Nutrition business, except for the Omega-3 business, and its divestment to FMC of a portion of DuPont’s Crop Protection business.

November 1, 2017

·

9 min read

Drug Development

University of Oxford and Sound Pharma Begin Phase II Clinical Trial on Novel Treatment for Bipolar Disorder

University of Oxford and Sound Pharma, are pleased to announce the initiation of a Phase II clinical trial of SPI-1005 for the treatment of patients with bipolar disorder.

November 1, 2017

·

2 min read

BioCapital

Smiths Detection Educates First Responders on Technology to Protect Against the Dangers of Fentanyl Exposure

The series of workshops will explore scenarios where responders can utilize field-based detection and identification systems to mitigate the threat of exposure to the potentially lethal opioid.

November 1, 2017

·

2 min read

Drug Development

Novoclem Presents Promising New Data at the North America Cystic Fibrosis Conference on November 2, 2017

The in vitro work, carried out by researchers at Southern Research Institute showed that BIOC51 was bactericidal against the following pathogens, several of which have been categorized as a significant public health threat according to the CDC.

November 1, 2017

·

4 min read

Policy

Ultragenyx and Kyowa Hakko Kirin Announce FDA Not Currently Planning to Hold Advisory Committee Meeting for Burosumab Biologics License Application

The regulatory review process will be proceeding as expected; PDUFA Date Of April 17, 2018.

November 1, 2017

·

6 min read

Drug Development

Spyryx Biosciences Release: Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference

Of significance, SPX-101 increased ASL height in all cells tested, including those carrying Class I CFTR mutations that lack functional CFTR protein.

November 1, 2017

·

5 min read

Biotech Beach

Bionano Genome Mapping Found to Be Superior to Existing Clinical Tests for the Identification of Pathogenic Structural Variants in Duchenne Muscular Dystrophy

The work published in Genome Medicine demonstrates Bionano’s ability to accurately detect structural variants in a patient cohort

November 1, 2017

·

3 min read

Business

Momenta Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update

In Q3 of 2017, the Company recorded $10.9 million in product revenues from Sandoz’s sales of Glatopa 20 mg compared to $23.3 million for the same period in 2016.

November 1, 2017

·

14 min read